Wake and Sleep State Transitions on a Portable Electroencephalogram (EEG) Device in Narcolepsy Type 1 (NT1) and Healthy Participants

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

August 3, 2020

Primary Completion Date

April 29, 2021

Study Completion Date

May 4, 2021

Conditions
Healthy VolunteersNarcolepsy Type 1
Interventions
DEVICE

Portable EEG Device

Portable EEG device is lightweight and designed for nighttime wear.

DEVICE

Portable ECG Device

Portable ECG device is waterproof and will be adhered to the chest of the participant.

DEVICE

Accelerometry

Portable accelerometry device is noninvasive and will capture data on participant activity level, including intensity of movement, rest, and sleep.

Trial Locations (13)

10467

Sleep Wake Disorders Center, The Bronx

28037

Research Carolina Elite, LLC, Denver

29201

Bogan Sleep Consultants, LLC, Columbia

30328

NeuroTrials Research, Inc., Atlanta

33765

St Francis Medical Institute, Clearwater

43017

Ohio Sleep Medicine Institute, Dublin

44195

The Cleveland Clinic Foundation, Cleveland

45212

CTI Clinical Trial and Consulting Services, Cincinnati

45245

Intrepid Research, Cincinnati

46804

Fort Wayne Neurological Center, Fort Wayne

78229

Sleep Therapy & Research Center, San Antonio

80918

Delta Waves Sleep Disorders and Research Center, Colorado Springs

94063

Stanford School of Medicine, Redwood City

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Takeda Development Center Americas, Inc.

INDUSTRY

lead

Takeda

INDUSTRY